Comparison of Plasma Input and Reference Tissue Models for Analysing [11C]flumazenil Studies
暂无分享,去创建一个
Mark Lubberink | Ronald Boellaard | Maqsood Yaqub | Dick J Veltman | Adriaan A Lammertsma | R. Boellaard | D. Veltman | M. Lubberink | A. Lammertsma | M. Yaqub | W. Hoogendijk | E. Comans | U. Klumpers | Witte J G Hoogendijk | Jurgen E M Mourik | J. Mourik | Emile F Comans | Ursula M H Klumpers | Cassandra Zuketto | C. Zuketto
[1] D. R. Turton,et al. An automated system based on solid phase extraction and HPLC for the routine determination in plasma of unchanged carbon-11 L-deprenyl Carbon-11 diprenorphine; carbon-11 flumazenil; Carbon-11 raclopride and Carbon-11 Scherring 23390 , 1993 .
[2] B Walder,et al. Similarity and Robustness of PET and SPECT Binding Parameters for Benzodiazepine Receptors , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[3] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[4] R. Koeppe,et al. Parametric in vivo imaging of benzodiazepine receptor distribution in human brain , 1991, Annals of neurology.
[5] François Mauguière,et al. Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study. , 2005, Brain : a journal of neurology.
[6] J. Baron,et al. Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies , 1991, European Journal of Drug Metabolism and Pharmacokinetics.
[7] C Crouzel,et al. Quantification of Benzodiazepine Receptors in Human Brain Using PET, [11C]Flumazenil, and a Single-Experiment Protocol , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Karl J. Friston,et al. Cortical grey matter and benzodiazepine receptors in malformations of cortical development. A voxel-based comparison of structural and functional imaging data. , 1997, Brain : a journal of neurology.
[9] Js Duncan,et al. QUANTIFICATION OF BENZODIAZEPINE RECEPTORS IN-VIVO USING C-11 FLUMAZENIL - APPLICATION OF THE STEADY-STATE PRINCIPLE , 1993 .
[10] D E Kuhl,et al. Compartmental Analysis of [11C]Flumazenil Kinetics for the Estimation of Ligand Transport Rate and Receptor Distribution Using Positron Emission Tomography , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[11] Gerald Q. Maguire,et al. Comparison and evaluation of retrospective intermodality brain image registration techniques. , 1997, Journal of computer assisted tomography.
[12] R. P. Maguire,et al. Consensus Nomenclature for in vivo Imaging of Reversibly Binding Radioligands , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[13] Giovanni Lucignani,et al. GABAA receptor abnormalities in Prader–Willi syndrome assessed with positron emission tomography and [11C]flumazenil , 2004, NeuroImage.
[14] D E Kuhl,et al. Differentiation of Radioligand Delivery and Binding in the Brain: Validation of a Two-Compartment Model for [11C]Flumazenil , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[15] Michael S. Beauchamp,et al. A parametric study of overt and covert shifts of spatial attention , 2000, NeuroImage.
[16] D Comar,et al. Kinetics and displacement of [11C]RO 15-1788, a benzodiazepine antagonist, studied in human brain in vivo by positron tomography. , 1985, European journal of pharmacology.
[17] Philippe Millet,et al. Evaluation of the Reference Tissue Models for PET and SPECT Benzodiazepine Binding Parameters , 2002, NeuroImage.
[18] H. Akaike. A new look at the statistical model identification , 1974 .
[19] T. Jones,et al. Spectral Analysis of Dynamic PET Studies , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[20] J. S. Duncan,et al. Benzodiazepine Receptor Quantification in vivo in Humans Using [11C]Flumazenil and PET: Application of the Steady-State Principle , 1995, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[21] Ronald Boellaard,et al. Characteristics of a new fully programmable blood sampling device for monitoring blood radioactivity during PET , 2001, European Journal of Nuclear Medicine.
[22] H. Duvernoy. The Human Brain , 1999, Springer Vienna.
[23] Christer Halldin,et al. Maps of receptor binding parameters in the human brain — a kinetic analysis of PET measurements , 2004, European Journal of Nuclear Medicine.
[24] Roger N. Gunn,et al. Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PET , 1998, NeuroImage.
[25] B. Gulyás,et al. Regional increases in [11 C]flumazenil binding after epilepsy surgery , 1998, Acta neurologica Scandinavica.
[26] J. Baron,et al. Central benzodiazepine receptors in human brain: estimation of regional Bmax and KD values with positron emission tomography. , 1992, European journal of pharmacology.
[27] Guy Marchal,et al. Multimodality image registration by maximization of mutual information , 1997, IEEE Transactions on Medical Imaging.
[28] Christer Halldin,et al. Saturation analysis of specific 11C Ro 15‐1788 binding to the human neocortex using positron emission tomography , 1989 .
[29] Z Rattner,et al. Measurement of Benzodiazepine Receptor Number and Affinity in Humans Using Tracer Kinetic Modeling, Positron Emission Tomography, and [11C]Flumazenil , 1993, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[30] G. Sedvall,et al. IN-VIVO DEMONSTRATION OF REDUCED BENZODIAZEPINE RECEPTOR BINDING IN HUMAN EPILEPTIC FOCI , 1988, The Lancet.
[31] D J Brooks,et al. Abnormalities of grey and white matter [11C]flumazenil binding in temporal lobe epilepsy with normal MRI. , 2002, Brain : a journal of neurology.
[32] D J Brooks,et al. Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission , 2000, Neurology.
[33] G. Schwarz. Estimating the Dimension of a Model , 1978 .
[34] L. Barré,et al. Relationships between trait and state anxiety and the central benzodiazepine receptor: a PET study , 1999, The European journal of neuroscience.
[35] J. Baron,et al. Regional Specific Binding of [11C]RO 15 1788 to Central Type Benzodiazepine Receptors in Human Brain: Quantitative Evaluation by PET , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[36] H. Duvernoy,et al. The Human Brain: Surface, Three-Dimensional Sectional Anatomy with MRI, and Blood Supply , 1999 .
[37] A. Anand,et al. Cerebral benzodiazepine receptors in depressed patients measured with [123i]iomazenil SPECT , 2003, Biological Psychiatry.
[38] P N Leigh,et al. Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil. , 2000, Brain : a journal of neurology.
[39] A. Mans,et al. Regional Distribution and Kinetics of Three Sites on the GABAA Receptor: Lack of Effect of Portacaval Shunting , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[40] A. Lammertsma,et al. Simplified Reference Tissue Model for PET Receptor Studies , 1996, NeuroImage.
[41] V J Cunningham,et al. Decreased brain GABA(A)-benzodiazepine receptor binding in panic disorder: preliminary results from a quantitative PET study. , 1998, Archives of general psychiatry.
[42] D J Brooks,et al. Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.